Drug Type Antibody fusion proteins |
Synonyms Anti-EGFr/CD89 antibody |
Target |
Mechanism CD89 inhibitors(IgA Fc receptor inhibitors), EGFR antagonists(Epidermal growth factor receptor erbB1 antagonists) |
Therapeutic Areas |
Active Indication- |
Inactive Indication |
Originator Organization |
Active Organization- |
Inactive Organization |
Drug Highest PhaseDiscontinuedPhase 2 |
First Approval Date- |
Regulation- |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Neoplasms | Preclinical | US | - | - |
Neoplasms | Preclinical | - | - |
Phase 1 | 18 | (nvmzmigufc) = ixlyclghfv yqofqbovtu (hrozhwksok ) | - | 20 Jun 2006 |